BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8271063)

  • 1. Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99m macroaggregated albumin.
    Leung WT; Lau WY; Ho SK; Chan M; Leung NW; Lin J; Metreweli C; Johnson PJ; Li AK
    J Nucl Med; 1994 Jan; 35(1):70-3. PubMed ID: 8271063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arteriovenous shunts in patients with hepatic tumors.
    Ho S; Lau WY; Leung WT; Chan M; Chan KW; Johnson PJ; Li AK
    J Nucl Med; 1997 Aug; 38(8):1201-5. PubMed ID: 9255149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiography-based C-arm CT for the assessment of extrahepatic shunting before radioembolization.
    Heusner TA; Hamami ME; Ertle J; Hahn S; Poeppel T; Hilgard P; Bockisch A; Forsting M; Antoch G
    Rofo; 2010 Jul; 182(7):603-8. PubMed ID: 20183775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrahepatic arteriovenous shunting due to hepatocellular carcinoma and cirrhosis, and its change by transcatheter arterial embolization.
    Sugano S; Miyoshi K; Suzuki T; Kawafune T; Kubota M
    Am J Gastroenterol; 1994 Feb; 89(2):184-8. PubMed ID: 8304300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of myocutaneous adverse side effect due to intra-arterial chemotherapy by intra-arterial (99m)Tc-macroaggregated albumin administration in patients with bone and soft-tissue tumors.
    Taki J; Sumiya H; Higuchi T; Tsuchiya H; Takazawa K; Tomita K; Tonami N
    J Nucl Med; 2002 Nov; 43(11):1452-6. PubMed ID: 12411547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-to-normal uptake ratio of 90Y microspheres in hepatic cancer assessed with 99Tcm macroaggregated albumin.
    Ho S; Lau WY; Leung TW; Chan M; Chan KW; Lee WY; Johnson PJ; Li AK
    Br J Radiol; 1997 Aug; 70(836):823-8. PubMed ID: 9486047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indicators of Lung Shunt Fraction Determined by Technetium-99 m Macroaggregated Albumin in Patients with Hepatocellular Carcinoma.
    Kallini JR; Gabr A; Hickey R; Kulik L; Desai K; Yang Y; Gates VL; Riaz A; Salem R; Lewandowski RJ
    Cardiovasc Intervent Radiol; 2017 Aug; 40(8):1213-1222. PubMed ID: 28280976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors.
    Leung TW; Lau WY; Ho SK; Ward SC; Chow JH; Chan MS; Metreweli C; Johnson PJ; Li AK
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):919-24. PubMed ID: 7591903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres.
    Dancey JE; Shepherd FA; Paul K; Sniderman KW; Houle S; Gabrys J; Hendler AL; Goin JE
    J Nucl Med; 2000 Oct; 41(10):1673-81. PubMed ID: 11037997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of fluorodeoxyuridine uptake in the liver and colorectal hepatic metastases of human beings after arterial infusion.
    Ridge JA; Sigurdson ER; Daly JM
    Surg Gynecol Obstet; 1987 Apr; 164(4):319-23. PubMed ID: 2951882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of tumour vascularity using selective hepatic angiography as compared with intrahepatic-arterial technetium-99m macroaggregated albumin scan in hepatocellular carcinoma.
    Leung TW; Lau WY; Ho SK; Chan M; Leung NW; Lin J; Metreweli C; Johnson PJ; Li AK
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S33-6. PubMed ID: 8137482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of primary and secondary hepatic malignancies associated with hepatopulmonary shunting.
    Gaba RC; Zivin SP; Dikopf MS; Parvinian A; Casadaban LC; Lu Y; Bui JT
    Radiology; 2014 May; 271(2):602-12. PubMed ID: 24533871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatic arterial infusion of 32P-radionuclide microspheres for radiation therapy of hepatocellular carcinoma].
    Liang L; Huang J; Yin X; Lu M; Rao G; Ren Z; Li D; Kuang M
    Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):743-6. PubMed ID: 11829942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of angiotensin II on arteriovenous shunting assessed by hepatic arterial perfusion scintigraphy.
    Inoue Y; Machida K; Honda N; Takagi S; Ohtake T; Nishikawa J; Sasaki Y
    Am J Clin Oncol; 1997 Jun; 20(3):237-41. PubMed ID: 9167744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The afferent circulation of the liver in patients with primary hepatocellular carcinoma.
    Jakab F; Ráth Z; Schmal F; Nagy P; Faller J
    Hepatogastroenterology; 1995; 42(4):399-402. PubMed ID: 8586376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-arterial infusion of Tc-99m MAA: a case of highly selective targeting of liver metastases and shunting.
    Roos JC; Teule GJ
    Clin Nucl Med; 1994 Mar; 19(3):219-20. PubMed ID: 8033472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of gravity on drug distribution after port-catheter implantation for hepatic arterial infusion chemotherapy: evaluation of the relationship between the injection posture and intrahepatic perfusion on fused images acquired with a combined SPECT/CT system.
    Tamura Y; Ikeda O; Nakasone Y; Shiraishi S; Tomiguchi S; Yamashita Y; Takamori H; Baba H
    Acad Radiol; 2009 Jun; 16(6):662-8. PubMed ID: 19268610
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Stephens RW; Tredwell GD; Knox KJ; Philip LA; King DW; Debono KM; Bell JL; Senden TJ; Tanudji MR; Winter JG; Bickley SA; Tapner MJ; Jones SK
    Int J Nanomedicine; 2019; 14():889-900. PubMed ID: 30774340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies of hemodynamics of hepatocellular carcinoma by Tc 99 m-MAA scintigraphy--especially effects of hepatic arterial occlusion].
    Yano S; Tarumi T; Tamura K; Nakase A
    Nihon Gan Chiryo Gakkai Shi; 1988 Jun; 23(6):1248-56. PubMed ID: 2852703
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulmonary uptake of technetium 99m macroaggregated albumin: a predictor of gastrointestinal toxicity during hepatic artery perfusion.
    Kaplan WD; Come SE; Takvorian RW; Laffin SM; Gelman RS; Weiss GR; Garnick MB
    J Clin Oncol; 1984 Nov; 2(11):1266-9. PubMed ID: 6491704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.